The Immunoregulatory Role of the Endogenous Cannabinoid Anandamide [ 2002-01-01 - 2006-12-31 ]

Research Grant

Researchers: A/Prof Timothy Roberts (Chief Investigator) ,  Dr Deborah Hodgson (Chief Investigator) ,  Prof Kenneth Beagley (Chief Investigator)

Brief description The Immunoregulatory Role of the Endogenous Cannabinoid Anandamide. Anandamides are naturally occurring fatty acids that act at the cannabinoid receptor expressed in the brain and periphery. A new proposal by our research group challenges traditional models of the disease process by suggesting that the anandamide system is an important imunoregulatory system that can be targeted by invading pathogens. We propose that disruption to the anandamide system, by bacteria or viruses acting at the receptor to block immunological responses, contributes to chronic illness states. At this point we have good evidence that anandamides are immunoregulators, however, we have very little knowledge of their precise physiological role. The aim of this research is to begin to characterise the immunoregulatory role of the anandamide system. This project will provide a comprehensive understanding of this endogenous control system, the immunological properties of which have not previously been described. The outcome of this research may lead to the identification of new avenues for the development of pharmaceutical interventions that can target this system.

Funding Amount $50,000

Funding Scheme Discovery Projects

View this grant in the ARC Data Portal